Heron Therapeutics Inc (HRTX)
1.28
+0.07
(+5.79%)
USD |
NASDAQ |
Nov 14, 11:13
Heron Therapeutics Max Drawdown (5Y): 98.09% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.09% |
| September 30, 2024 | 98.09% |
| August 31, 2024 | 98.09% |
| July 31, 2024 | 98.09% |
| June 30, 2024 | 98.09% |
| May 31, 2024 | 98.09% |
| April 30, 2024 | 98.09% |
| March 31, 2024 | 98.09% |
| February 29, 2024 | 98.09% |
| January 31, 2024 | 98.09% |
| December 31, 2023 | 98.09% |
| November 30, 2023 | 98.09% |
| October 31, 2023 | 97.88% |
| September 30, 2023 | 97.21% |
| August 31, 2023 | 97.21% |
| July 31, 2023 | 97.21% |
| June 30, 2023 | 97.21% |
| May 31, 2023 | 97.13% |
| April 30, 2023 | 96.40% |
| March 31, 2023 | 96.40% |
| February 28, 2023 | 94.64% |
| January 31, 2023 | 94.64% |
| December 31, 2022 | 94.64% |
| November 30, 2022 | 94.52% |
| October 31, 2022 | 94.52% |
| Date | Value |
|---|---|
| September 30, 2022 | 94.52% |
| August 31, 2022 | 94.52% |
| July 31, 2022 | 94.52% |
| June 30, 2022 | 94.52% |
| May 31, 2022 | 92.62% |
| April 30, 2022 | 89.24% |
| March 31, 2022 | 88.98% |
| February 28, 2022 | 83.38% |
| January 31, 2022 | 80.69% |
| December 31, 2021 | 80.12% |
| November 30, 2021 | 78.21% |
| October 31, 2021 | 75.88% |
| September 30, 2021 | 75.88% |
| August 31, 2021 | 75.88% |
| July 31, 2021 | 75.64% |
| June 30, 2021 | 75.64% |
| May 31, 2021 | 75.64% |
| April 30, 2021 | 75.64% |
| March 31, 2021 | 75.64% |
| February 28, 2021 | 75.64% |
| January 31, 2021 | 75.64% |
| December 31, 2020 | 75.64% |
| November 30, 2020 | 75.64% |
| October 31, 2020 | 75.64% |
| September 30, 2020 | 75.64% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
70.13%
Minimum
Nov 2019
98.09%
Maximum
Nov 2023
86.54%
Average
90.93%
Median
Max Drawdown (5Y) Benchmarks
| Journey Medical Corp | -- |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -65.06 |
| Beta (5Y) | 1.807 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 97.10% |
| Historical Sharpe Ratio (5Y) | -0.4299 |
| Historical Sortino (5Y) | -0.9188 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.08% |